Is saliva suitable for therapeutic monitoring of anticonvulsants in children: An evaluation in the routine clinical setting

Therapeutic Drug Monitoring

Volumn 19, Issue 6, 1997, Pages 637-642

  Gorodischer, Rafael ^a,c,d   Burtin, Pascale ^a   Verjee, Zul ^a   Hwang, Paul ^b   Koren, Gideon ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Anticonvulsants; Saliva; TDM

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CITRIC ACID; CLOBAZAM; NORCLOBAZAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; CHILD; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG SALIVA LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; EPILEPSY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; EPILEPSY; EVALUATION STUDIES; FEMALE; HUMANS; IMMUNOASSAY; INFANT; MALE; SALIVA;

EID: 0031441674     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199712000-00006     Document Type: Article

References (32)

1. Gorodischer R, Koren G. Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring. Dev Pharmacol Ther 1992;19:161-77.
2. Gorodischer R, Burtin P, Hwang P, Levine M, Koren G. Saliva versus blood sampling for therapeutic drug monitoring in children: patient and parental preferences and an economic analysis. Ther Drug Monit 1994;16:437-43.
3. Tal A, Aviram M, Gorodischer R. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma. J Allergy Clin Immunol 1990; 86:238-43.
4. Boreus LO. Therapeutic drug monitoring. In: Yaffe SJ, Aranda JV, eds. Pediatric Pharmacology: Therapeutic Principles in Practice. 2nd ed. Philadelphia, PA: WB Saunders, 1992;63-71.
5. Reynolds F, Ziroyanis PN, Jones NF, Smith SE. Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Lancet 1976;ii:384-6.
6. Lifshitz M, Ben-Zvi Z, Gorodischer R. Monitoring phenytoin therapy using citric acid-stimulated saliva in infants and children. Ther Drug Monit 1990;12:334-8.
7. Aviram M, Tal A, Ben-Zvi Z, Gorodischer R. Monitoring theophylline therapy using citric acid-stimulated saliva in infants and children with asthma. Pediatrics 1987;80:894-7.
8. Rylance GW, Moreland TA. Saliva carbamazepine and phenytoin level monitoring. Arch Dis Child 1981;56:637-52.
9. Blanchard J, Harvey S, Morgan WJ. Relationship between serum and saliva theophylline levels in patients with cystic fibrosis. Ther Drug Monit 1992;14:48-54.
10. Anavekar SN, Saunders RH, Wardell WM, Shoulson I, Emmings FG, Cook CE, Gringeri AJ. Parotid and whole saliva in the prediction of serum total and free phenytoin concentrations. Clin Pharmacol Ther 1978;24:629-37.
11. Jusko W, Gerbracht L, Golden LH, Koup J. Digoxin concentration in serum and saliva. Res Comm Chem Path Pharmacol 1975;10: 189-92.
12. Armitage P. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications, 1971;147-66,302-48.
13. Choonara IA, Rane A. Therapeutic drug monitoring of anticonvulsants: state of the art. Clin Pharmacokinet 1990;18:318-28.
14. Mimaki T, Walson PD, Suzuki Y. Anticonvulsants. In: Yaffe SJ, Aranda JV, eds. Pediatric Pharmacology: Therapeutic Principles in Practice. 2nd ed. Philadelphia, PA: Saunders, 1992:287-302.
15. Schoenenberger RA, Tanasijevic MJ, Jha A, Bates DW. Appropriateness of antiepileptic drug level monitoring. JAMA 1995;274: 1622-6.
16. Bachman K, Forney RB Jr, Voeller K. Monitoring phenytoin in salivary and plasma ultrafiltrates of pediatric patients. Ther Drug Monit 1983;5:325-9.
17. Paxton JW. Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects. Clin Pharmacol Ther 1980;27:170-8.
18. Knott C, Thomas AH, Reynolds F. Phenytoin-valproate interaction. Br Med J 1982;284:13-6.
19. Rodin EA, DeSoussa G, Haidukewych D, Lohdi R, Berchou RC. Dissociation between free and bound phenytoin levels in presence of valproate sodium. Arch Neurol 1981;38:240-2.
20. Knott C, Reynolds F. The place of saliva in antiepileptic drug monitoring. Ther Drug Monit 1984;6:35-41.
21. McAuliffe JJ, Sherwin AL, Leppik IE, Bayle SA, Pippenger CE. Salivary levels of anticonvulsants: a practical approach to drug monitoring. Neurology 1977;27:409-13.
22. Dvorchick BH, Vessell ES. Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring. Clin Chem 1977;22: 868-78.
23. Nishihara K, Katsuyosky U, Saitoh Y, Honda Y, Nakagawa F, Tamwia Z. Estimation of plasma unbound phenobarbital concentration by using mixed saliva. Epilaepsia 1979;20:37-45.
24. Cook CE, Amerson E, Poole WK, Lesser P, O'Tuama L. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay. Clin Pharmacol Ther 1975;18:742-7.
25. Goldsmith RF, Ouvrier RA. Salivary anticonvulsant levels in children: a comparison of methods. Ther Drug Monit 1981;3:151-7.
26. Tokugawa K, Ueda K, Fujito H, Kurokawa T. Correlation between the saliva and free serum concentration of phenobarbital in epileptic children. Eur J Pediatr 1986;145:401-2.
27. Miles MV, Tennison MB, Greenwood RS, Benoit SE, Thorn MD. Messenheimer JA. Ehle AL. Evaluation of the Ames Seralyzer for the determination of carbamazepine, phenobarbital and phenytoin concentrations in saliva. Ther Drug Monit 1990;12:501-10.
28. Miles MV, Tennison MB, Greenwood RS. Intraindividual variability of carbamazepine, phenobarbital and phenytoin concentrations in saliva. Ther Drug Monit 1991;13:166-71.
29. Friedman IM, Litt IF, Henson R, Holzman D, Halverson D. Saliva phenobarbital and phenytoin concentrations in epileptic adolescents. J Pediatr 1981;98:645-7.
30. Mucklow JC, Bacon CJ, Hierons Am, Webb JKG, Rawlins MD. Monitoring of phenobarbitone and phenytoin therapy in small children by salivary samples. Ther Drug Monit 1981;3:275-7.
31. Guberman A, Couture M, Blaschuk K, Sherwin A. Add-on trial of clobazam in intractable adult epilepsy with plasma levels correlations. Can J Neurol Sci 1990;17:311-6.
32. Bardy AH, Seppala T, Salokorpi T, Grandstrom ML, Santavouri P. Monitoring of concentration of clobazam and norclobazam in serum and saliva of children with epilepsy. Brain Dev 1991;13: 174-9.